e-learning
resources
London 2016
Sunday, 04.09.2016
Molecular targets in pulmonary disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe dyspnea
Victoria Lorenzon (buenos aires, Argentina), Victoria Lorenzon, Soledad Saez, Alejandra Pereyra, Jose Oyhamburu, Patricia Sorroche
Source:
International Congress 2016 – Molecular targets in pulmonary disease
Session:
Molecular targets in pulmonary disease
Session type:
Thematic Poster
Number:
882
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Victoria Lorenzon (buenos aires, Argentina), Victoria Lorenzon, Soledad Saez, Alejandra Pereyra, Jose Oyhamburu, Patricia Sorroche. Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe dyspnea. Eur Respir J 2016; 48: Suppl. 60, 882
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
MiR-320c regulates SERPINA1 expression and is associated with pulmonary disease in alpha-1-antitrypsin deficiency
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
Specific airway resistance as a marker of early disease in alpha-1 antitrypsin deficiency
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015
Degree of knowledge among physicians about the diagnosis and treatment of alpha-1 antitrypsin deficiency
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
A new SERPINA-1 missense mutation associated with alpha-1 antitrypsin deficiency and bronchiectasis.
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017
Prevalence of alpha-1 antitrypsin deficiency (AATD) and frequencies of alleles PI*S and PI*Z in patients with COPD in Brazil
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013
Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry
Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases
Year: 2015
Molecular characterization of novel PiS-like alleles identified in Spanish patients with Alpha-1 antitrypsin deficiency
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
Bronchiectasis but not emphysema is more prevalent in non-PiZ alpha-1 antitrypsin deficiency (AATD) COPD than in usual COPD
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014
Laboratory testing of individuals with severe α1-antitrypsin deficiency in three European centres
Source: Eur Respir J 2010; 35: 960-968
Year: 2010
Screening for alpha1-antitrypsin deficiency at a university hospital
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Diagnosis of alpha 1 antitrypsin deficiency in primary care
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
Screening for α1-Pi deficiency in patients with lung diseases
Source: Eur Respir J 2002; 20: 319-324
Year: 2002
The Irish national alpha-1 antitrypsin deficiency targeted detection programme
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013
Prevalence of mutations in the alpha 1 antitrypsin gene in patients with pulmonary emphysema
Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions
Year: 2019
Electrophoresis of blood serum: A helpful diagnostic tool for identifying respiratory patients with alpha1-antitrypsin deficiency
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Severe alpha-1-antitrypsin deficiency (A1ATD) caused by Q0
Ourém
mutation: A clinical characterization
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010
Clinical features of alpha one antitrypsin deficiency in COPD
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Tracing down the evolutionary history of Q0
Ourém
, a rare allele associated with severe alpha-1-antitrypsin deficiency (AATD)
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Screening of chronic liver disease by transient elastography in patients with lung disease associated with alpha-1 antitrypsin deficiency.
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept